AI
EXAS

Axiom Investors’s Exact Sciences EXAS Stock Holding History

Axiom Investors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-253,780
Closed -$22.9M – 122
2019
Q3 		$22.9M Buy
253,780
+48,284
+23% +$5.5M 0.62% 47
2019
Q2 		$24.3M Buy
205,496
+64,248
+45% +$6.47M 0.66% 40
2019
Q1 		$12.2M Sell
141,248
-105,552
-43% -$8.98M 0.38% 51
2018
Q4 		$15.6M Sell
246,800
-19,460
-7% -$1.34M 0.54% 48
2018
Q3 		$21M Buy
266,260
+176,540
+197% +$11.5M 0.6% 43
2018
Q2 		$5.36M Buy
89,720
+52,410
+140% +$2.82M 0.16% 76
2018
Q1 		$1.5M Sell
37,310
-32,693
-47% -$1.59M 0.04% 132
2017
Q4 		$3.68M Sell
70,003
-37,191
-35% -$1.99M 0.09% 100
2017
Q3 		$5.05M Buy
+107,194
New +$4.31M 0.11% 89

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Axiom Investors's EXAS Position: Q4 2019 in Review

Axiom Investors sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 253,780 shares — an estimated $22.9M sold.

Axiom Investors first reported a position in EXAS in Q3 2017 and held it in 9 quarters. The position peaked at $24.3M in Q2 2019. 527 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

  • Axiom Investors reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
  • Axiom Investors sold 253,780 Exact Sciences shares in Q4 2019, an estimated $22.9M.
  • Axiom Investors first reported a position in Exact Sciences in Q3 2017 and held it in 9 quarters.
  • Axiom Investors's Exact Sciences position peaked at $24.3M in Q2 2019.
  • 527 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Axiom Investors's 13F filing for Q4 2019, filed 13 Feb 2020.